News
Coca-Cola Stock: 62nd Consecutive Annual Dividend Increase Beckons (NYSE:KO)
The Coca-Cola Company (NYSE:KO) investors like myself tend to look forward to February of every year as the company's annual…
Equitrans Midstream Stock: Could Be The ‘MVP’ Of Your Portfolio (NYSE:ETRN)
Shares of Equitrans Midstream (NYSE:ETRN) have had a stellar twelve months, rising about 50% as its major expansion pipeline project…
Chart Of The Week: ISM Services Employment Collapse
This is a chart that people will be talking about for a long time now. This shows the ISM Services…
S&P 500 Earnings: Jump In Forward Estimate Worth Noting
For the 2nd week in a row, there was no data forthcoming from IBES and Refinitiv, which is actually understandable,…
Riot Platforms Stock: I Doubt It Will Ever Be A Buy (NASDAQ:RIOT)
An acquaintance of mine asked for my opinion on Riot Platforms (NASDAQ:RIOT), a company whose primary operation is mining Bitcoin…
Verrica Pharmaceuticals Stock: There Is A Silver Lining With YCANTH’s Commercialization
Verrica Pharmaceuticals (NASDAQ:VRCA) recently celebrated, its 5-year listing on Nasdaq after it rallied 136.46% (YoY). Notable events for the company…
Hormel: This Dividend King Is Getting Very Old (NYSE:HRL)
It has been a long-standing view of mine that the consumer staples sector is likely riskier than many believe. There…
Anavex, Cassava, And Panax: Agents To Modify Alzheimer’s Disease
Anavex’s (AVXL) 2-73/blarcamesine is a sigma-1 receptor agonist; Cassava Sciences’ (SAVA) simufilam may be sigma-1 receptor agonists (based on its…